Howland Capital Management LLC Amgen Inc Transaction History

Howland Capital Management LLC

$2.07 Billion
Q2 2024

A detailed history of Howland Capital Management LLC transactions in Amgen Inc stock. As of the latest transaction made, Howland Capital Management LLC holds 2,103 shares of AMGN stock, worth $672,076. This represents 0.03% of its overall portfolio holdings.

Number of Shares

2,103

Previous 2,100 0.14%

Holding current value

$672,076

Previous $597,000 10.05%

% of portfolio

0.03%

Previous 0.03%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$262.75 - $319.31 $788 - $957	3 Added 0.14%	2,103 $657,000
Q1 2024 May 03, 2024	SELL	$268.87 - $324.56 $33,608 - $40,570	-125 Reduced 5.62%	2,100 $597,000
Q4 2023 Jan 23, 2024	BUY	$255.7 - $288.46 $62,646 - $70,672	245 Added 12.37%	2,225 $640,000
Q3 2023 Oct 17, 2023	SELL	$218.65 - $271.46 $91,833 - $114,013	-420 Reduced 17.5%	1,980 $532,000
Q2 2023 Jul 28, 2023	BUY	$214.27 - $253.37 $21,427 - $25,337	100 Added 4.35%	2,400 $532,000
Q1 2023 May 05, 2023	BUY	$225.79 - $275.2 $27,094 - $33,024	120 Added 5.5%	2,300 $556,000
Q3 2022 Oct 17, 2022	SELL	$224.46 - $253.15 $1,346 - $1,518	-6 Reduced 0.27%	2,180 $491,000
Q2 2022 Jul 22, 2022	BUY	$230.71 - $256.74 $125,275 - $139,409	543 Added 33.05%	2,186 $532,000
Q1 2022 Apr 27, 2022	SELL	$219.27 - $242.57 $5,701 - $6,306	-26 Reduced 1.56%	1,643 $397,000
Q4 2021 Jan 26, 2022	SELL	$198.88 - $227.6 $12,529 - $14,338	-63 Reduced 3.64%	1,669 $375,000
Q3 2021 Oct 25, 2021	SELL	$212.27 - $248.7 $54,128 - $63,418	-255 Reduced 12.83%	1,732 $368,000
Q1 2021 Apr 28, 2021	SELL	$221.91 - $258.6 $33,286 - $38,790	-150 Reduced 7.02%	1,987 $494,000
Q4 2020 Jan 26, 2021	SELL	$216.38 - $257.67 $9,520 - $11,337	-44 Reduced 2.02%	2,137 $491,000
Q2 2020 Jul 15, 2020	SELL	$197.81 - $242.74 $10,681 - $13,107	-54 Reduced 2.42%	2,181 $514,000
Q1 2020 Apr 13, 2020	SELL	$182.24 - $241.7 $94,947 - $125,925	-521 Reduced 18.9%	2,235 $453,000
Q4 2019 Jan 23, 2020	SELL	$189.21 - $243.2 $59,222 - $76,121	-313 Reduced 10.2%	2,756 $664,000
Q3 2019 Oct 22, 2019	BUY	$174.11 - $208.62 $200,922 - $240,747	1,154 Added 60.26%	3,069 $594,000
Q2 2019 Jul 17, 2019	SELL	$166.7 - $195.41 $8,335 - $9,770	-50 Reduced 2.54%	1,915 $353,000
Q1 2019 Apr 22, 2019	SELL	$180.87 - $203.88 $3,798 - $4,281	-21 Reduced 1.06%	1,965 $373,000
Q4 2018 Jan 23, 2019	SELL	$178.4 - $208.25 $4,995 - $5,831	-28 Reduced 1.39%	1,986 $387,000
Q3 2018 Oct 25, 2018	SELL	$185.29 - $208.89 $555 - $626	-3 Reduced 0.15%	2,014 $417,000
Q1 2018 May 02, 2018	BUY	$169.43 - $198.0 $5,252 - $6,138	31 Added 1.56%	2,017 $344,000
Q3 2017 Oct 30, 2017	BUY	$167.29 - $191.0 $332,237 - $379,326	1,986	1,986 $370,000

Others Institutions Holding AMGN

# of Institutions

3,057

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.3M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Howland Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Howland Capital Management LLC with notifications on news.

Account

Howland Capital Management LLC Amgen Inc Transaction History